EZH2 and hepatocellular carcinoma: Knockdown of HDAC5 in HCC cells induced TAp63 expression, accompanied by increased H3K9ac levels at the TAp63 promoter.45 Our study demonstrated that BCL-6 can form complexes with EZH2 and HDAC5, mediating their binding to the miR-142 promoter.